Loading clinical trials...
Loading clinical trials...
This is a Phase II research study that is designed for patients who have small cell lung cancer (SCLC) that is no longer responding to treatment. Patients will receive picoplatin, a new platinum-based...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Poniard Pharmaceuticals
NCT05671510 · Non Small Cell Lung Cancer
NCT06043817 · Non-Small Cell Lung Cancer, NSCLC, and more
NCT07177937 · Small Cell Lung Cancer, Melanoma, and more
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT06646276 · Extensive-Stage Small Cell Lung Cancer
Genesis Cancer Center
Hot Springs, Arkansas
Study Site
Los Angeles, California
Comprehensive Cancer Center
Palm Springs, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions